reports
- GlobalData Healthcare Department
Achaogen Inc (AKAO) - Financial Analysis Review
Achaogen Inc (AKAO) - Financial Analysis Review Summary Achaogen Inc (Achaogen) discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company’s pipeline product portfolio includes plazomicin, which is a phase III clinical trial stage compound for the treatment of bacterial infections caused by MDR enterobacteriaceae. It is also developing agents for the treatment of gram-negative infections. GlobalData's Acha...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.